High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance
García-Marco, José A, Jiménez, Javier López, Recasens, Valle, Zarzoso, Miguel Fernández, González-Barca, Eva, De Marcos, Nieves Somolinos, Ramírez, M Jose, Parraga, Francisco Javier Peñalver, Yañez, Lucrecia, De La Serna Torroba, Javier, Malo, Maria Dolores Garcia, Ariznavarreta, Guillermo Deben, Persona, Ernesto Perez, Guinaldo, M Angeles Ruiz, De Paz Arias, Raquel, Llanos, Elena Bañas, Jarque, Isidro, Valle, M Del Carmen Fernandez, Tatay, Ana Carral, De Oteyza, Jaime Perez, Martin, Eva Maria Donato, Fernández, Inmaculada Perez, Martinez, Rafael Martinez, Costa, M Angeles Andreu, Champ, Diana, Suarez, Julio García, Díaz, Marcos González, Ferrer, Secundino, Carbonell, Félix, García-Vela, José A
Published in Haematologica (Roma) (01.11.2019)
Published in Haematologica (Roma) (01.11.2019)
Get full text
Journal Article
Outcomes in high-risk subgroups after fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Up to 5.5 years of follow-up in the phase 2 CAPTIVATE study
Wierda, William G., Jacobs, Ryan, Barr, Paul M., Allan, John N., Siddiqi, Tanya, Tedeschi, Alessandra, Kipps, Thomas J., O'Brien, Susan Mary, Badoux, Xavier C., Visentin, Andrea, Lasica, Masa, Carney, Dennis, Elinder Camburn, Anna, De La Serna Torroba, Javier, Szafer-Glusman, Edith, Zhou, Cathy, Szoke, Anita, Dean, James P., Ghia, Paolo, Tam, Constantine S.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain
Moreno-Martínez, Estela, de la Serna-Torraba, Javier, Escudero-Vilaplana, Vicente, Hernández-Rivas, José Ángel, Sánchez-Cuervo, Marina, Sánchez-Hernández, Raquel
Published in Farmacia hospitalaria (01.05.2022)
Published in Farmacia hospitalaria (01.05.2022)
Get full text
Journal Article
Obinutuzumab (GA101) plus chlorambucil (Clb) or rituximab (R) plus Clb versus Clb alone in patients with chronic lymphocytic leukemia (CLL) and preexisting medical conditions (comorbidities): Final stage 1 results of the CLL11 (BO21004) phase III trial
Goede, Valentin, Fischer, Kirsten, Humphrey, Kathryn, Asikanius, Elina, Busch, Raymonde, Engelke, Anja, Wendtner, Clemens M., Samoylova, Olga, Chagorova, Tatiana, Dilhuydy, Marie-Sarah, De La Serna Torroba, Javier, Illmer, Thomas, Opat, Stephen, Owen, Carolyn, Kreuzer, Karl A, Langerak, Anton W, Ritgen, Matthias, Stilgenbauer, Stephan, Wenger, Michael, Hallek, Michael
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient
Barberán, José, Mensa, Josep, Llamas, Juan Carlos Vallejo, Ramos, Isidro Jarque, Ruiz, Juan Carlos García, Marín, José Rafael Cabrera, Tello, Patricia Baltasar, Massana, Montse Batlle, Vidal, Juan Besalduch, Viñas, José Manuel Calvo, Huelva, Francisco Javier Capote, Pons, Enric Carreras, Mediavilla, Joaquín Díaz, Morfa, Miguel L Díaz, Barrigón, Fernando Escalante, Avellán, Pascual Fernández, López, Sebastián Garzón, García, Carlos Grande, Maraver, Dolores Hernández, Guía, Ana López de la, Jiménez, Javier López, Chacón, Eusebio Martín, Rubio, Mayte Olave, Oteyza, Jaime Pérez de, Ramírez, Gemma Ramírez, Contreras, Rafael Rojas, Barbero, Alejandro Román, Tarrats, Montserrat Rovira, Félix, Daniel Rubio, Godoy, Pedro Sánchez, Salinas, Andrés Sánchez, Alonso, Miguel A Sanz, Torroba, Javier de la Serna, Ferreiras, David Valcárcel, López, Lourdes Vázquez, García, José M Aguado, Perea, José Ramón Azanza, Moreno, Rafael Cantón, Cáncer, Ramón Cisterna, Abete, Jesús Fortún, Rodríguez, Julio García, Gómez, Joaquín Gómez, Pedrosa, Elia Gómez García de la, Baranda, José Miguel Montejo, García, F Javier Pemán, Camps, Isabel Ruiz, Lleti, Miguel Salavert, Cisneros, Julián de la Torre
Published in Revista española de quimioterapia (01.12.2011)
Get full text
Published in Revista española de quimioterapia (01.12.2011)
Journal Article
Cytogenetic risk categories in acute myeloid leukemia: a comparison between MRC (Medical Research Council) and SWOG (Southwest Oncology Group) models
Martín Ramos, María Luisa, López Pastor, Margarita, de la Serna Torroba, Javier, Ayala, Rosa, García Alonso, Luis, Barreiro Miranda, Emilia
Published in Medicina clínica (28.06.2003)
Published in Medicina clínica (28.06.2003)
Get more information
Journal Article